Glucagon, from past to present: a century of intensive research and controversies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucagon, from past to present: a century of intensive research and controversies
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume 11, Issue 2, Pages 129-138
Publisher
Elsevier BV
Online
2022-12-23
DOI
10.1016/s2213-8587(22)00349-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
- (2022) Thomas Karagiannis et al. DIABETOLOGIA
- Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
- (2022) Tim Heise et al. Lancet Diabetes & Endocrinology
- Mediators of Amylin Action in Metabolic Control
- (2022) Christina N. Boyle et al. Journal of Clinical Medicine
- The Liver-Alpha Cell Axis in Health and in Disease
- (2022) Michael M. Richter et al. DIABETES
- New Developments in Glucagon Treatment for Hypoglycemia
- (2022) LesleAnn Hayward Story et al. DRUGS
- Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
- (2022) Marlena M. Holter et al. Frontiers in Endocrinology
- Insights into the Role of Glucagon Receptor Signaling in Metabolic Regulation from Pharmacological Inhibition and Tissue-Specific Knockout Models
- (2022) A Tate Lasher et al. Biomedicines
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
- (2022) Tamer Coskun et al. Cell Metabolism
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2022) Melanie J. Davies et al. DIABETOLOGIA
- Glucagonostatic Potency of GLP-1 in Patients with Type 2 Diabetes, in Patients with Type 1 Diabetes and in Healthy Controls
- (2021) Jonatan I. Bagger et al. DIABETES
- Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1
- (2021) Scott A. Campbell et al. Islets
- Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
- (2021) Rajaa Nahra et al. DIABETES CARE
- Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture
- (2021) Jens Juul Holst DIABETES
- Peptides in the regulation of glucagon secretion
- (2021) Daniel B. Andersen et al. PEPTIDES
- GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia
- (2020) Maria J Redondo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
- (2020) Laurie L. Baggio et al. Molecular Metabolism
- A Review of the Efficacy and Cardiovascular Safety of Amylin Analogues
- (2020) Rithika Mary Koshy et al. Current Drug Safety
- Glucagon Receptor Signaling and Lipid Metabolism
- (2019) Katrine D. Galsgaard et al. Frontiers in Physiology
- Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
- (2019) Brian Finan et al. DIABETES
- Glucagon Regulation of Energy Expenditure
- (2019) Maximilian Kleinert et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon
- (2019) Vivian T. Thieu et al. DIABETES OBESITY & METABOLISM
- Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes
- (2019) Maria J. Pereira et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Problem or solution: The strange story of glucagon
- (2018) R.V. Scott et al. PEPTIDES
- Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes
- (2017) André J. Scheen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery, characterization, and clinical development of the glucagon-like peptides
- (2017) Daniel J. Drucker et al. JOURNAL OF CLINICAL INVESTIGATION
- Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
- (2017) Firas H El-Khatib et al. LANCET
- Evidence of Extrapancreatic Glucagon Secretion in Man
- (2015) Asger Lund et al. DIABETES
- Inhibiting or antagonizing glucagon: making progress in diabetes care
- (2015) P. J. Lefèbvre et al. DIABETES OBESITY & METABOLISM
- A new paradigm for treating obesity and diabetes mellitus
- (2015) André J. Scheen et al. Nature Reviews Endocrinology
- Glucagon – Early breakthroughs and recent discoveries
- (2015) Bo Ahrén PEPTIDES
- Cardiovascular Actions of Incretin-Based Therapies
- (2014) John R. Ussher et al. CIRCULATION RESEARCH
- Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
- (2013) Daniel J. Drucker et al. Annual Review of Physiology
- Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes
- (2013) Mikkel B. Christensen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Structure of the human glucagon class B G-protein-coupled receptor
- (2013) Fai Yiu Siu et al. NATURE
- Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
- (2012) Roger H. Unger et al. JOURNAL OF CLINICAL INVESTIGATION
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Early milestones in glucagon research
- (2011) P. J. Lefèbvre DIABETES OBESITY & METABOLISM
- Physiologic action of glucagon on liver glucose metabolism
- (2011) C. J. Ramnanan et al. DIABETES OBESITY & METABOLISM
- Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
- (2011) Philip E. Cryer ENDOCRINOLOGY
- The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action
- (2010) K. J. Hare et al. DIABETES
- Paracrinology of islets and the paracrinopathy of diabetes
- (2010) R. H. Unger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
- (2009) R. A. DeFronzo DIABETES
- Somatostatin Secreted by Islet -Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function
- (2008) A. C. Hauge-Evans et al. DIABETES
- Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes
- (2008) Ivan Quesada et al. JOURNAL OF ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More